This article is more than 5 years old. Information may no longer be current.
Triple approach may be an option in keratoconus patients
Click Here to Manage Email Alerts
 Efekan Coskunseven |
ISTANBUL, Turkey - Implantation of a toric implantable Collamer lens after intracorneal ring implantation followed by corneal collagen cross-linking is an effective treatment sequence in patients with keratoconus, according to a speaker here.
The combination can stop progression and improve visual and refractive results, Efekan Coskunseven, MD, said at the winter meeting of the European Society of Cataract and Refractive Surgeons.
"With this triple strategy, we aim at improving vision as well as halting disease progression," Dr. Coskunseven said.
In a study, 14 eyes of nine patients were included. Keraring (Mediphacos) segment implantation was carried out first, using the IntraLase FS 60 (Abbott Medical Optics) ) to create the channels. Corneal collagen cross-linking followed after a mean interval of 7 months, and ICL (STAAR Surgical) implantation completed the procedure at a mean interval of 8 months. ICL power calculation was based on postoperative intracorneal ring plus corneal collagen cross-linking refraction.
After ICL implantation, a significant improvement in visual acuity was reported. The combined effect of intracorneal ring and corneal collagen cross-linking corneal reshaping and IOL correction allowed reduction of spherical equivalent from -16 D to -1 D and cylinder from -5 D to -1 D. Mean keratometry values decreased substantially.
"Only 14 eyes were included in this study, but at our hospital, we have used this triple approach in more than 1,000 cases. No significant endothelial cell loss was reported, and we only had two cases of cataract," Dr. Coskunseven said.
- Disclosure: Dr. Coskunseven has no direct financial interest in the products discussed in this article, nor is he a paid consultant for any companies mentioned.